(Alliance News) - OKYO Pharma Ltd on Wednesday said its OK-113 drug had "potent anti-inflammatory effects" in a model of dry eye disease in mice.Administering topical treatment of Read More
(Alliance News) - OKYO Pharma Ltd on Monday posted a narrowed annual loss mainly due to non repeat of a large impairment charge.The company's pretax loss for the year ended March 31 to Read More
LONDON (Alliance News) - OKYO Pharma Ltd on Friday said it will raise GBP400,000 via a share subscription to complete studies on drugs to treat inflammatory eye diseases and chronic biotechnology Read More
LONDON (Alliance News) - Okyo Pharma Ltd said on Thursday that Regent Mercantile Holdings Ltd has fully disposed of its 5% stake in the company in a deal on Tuesday.Shares in the firm 19% Read More
LONDON (Alliance News) - OKYO Pharma Ltd on Thursday said it will present preclinical results demonstrating anti-inflammatory activity and the potential of OKYO-0101 in the treatment of dry Pharma Read More
LONDON (Alliance News) - OKYO Pharma Ltd on Wednesday said preclinical studies of non-opioid painkiller BAM8 are expected to complete within the second quarter of 2019.Shares in the life up Read More
LONDON (Alliance News) - OKYO Pharma Ltd on Friday reported a significantly narrowed loss in the first half of its current financial year as it entered into two drug development life sciences and Read More
LONDON (Alliance News) - OKYO Pharma Ltd on Friday said it appointed Raj Patil as senior director of Research & Development.The biotechnology company said Patil is not assuming a on the Read More
LONDON (Alliance News) - OKYO Pharma Ltd on Tuesday posted a dramatically widened annual loss following the disposal of its entire interest in the capital of its mining subsidiary.Shares in Read More
